Joseph Romanelli Merck & Co., Inc. (MRK) insider trading activity

Joseph Romanelli is President, Human Health Int?l of Merck & Co., Inc.. Currently has a direct ownership of 20,716 shares of MRK, which is worth approximately $2.02 Million. The most recent transaction as insider was on May 02, 2024, when has been sold 1,115 shares (Common Stock) at a price of $128.8 per share, resulting in proceeds of $143,612. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.7K

0% 3M change

0.71% 12M change

Total Value Held $2.02 Million

Joseph Romanelli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 02 2024	SELL Payment of exercise price or tax liability	$143,612 $128.8 p/Share	1,115 Reduced 5.11%	20,716 Common Stock
May 02 2024	BUY Exercise of conversion of derivative security	$291,345 $128.8 p/Share	2,262 Added 9.39%	21,831 Common Stock
Feb 13 2024	SELL Open market or private sale	$124,890 $124.89 p/Share	1,000 Reduced 4.86%	19,569 Common Stock
Aug 02 2023	SELL Open market or private sale	$3,221 $107.37 p/Share	30 Reduced 0.15%	20,569 Common Stock
Apr 26 2023	BUY Open market or private purchase	$341 $113.68 p/Share	3 Added 0.01%	20,599 Common Stock
Mar 24 2023	SELL Open market or private sale	$3,662 $104.65 p/Share	35 Reduced 0.17%	20,596 Common Stock
Mar 20 2023	BUY Open market or private purchase	$14,343 $105.47 p/Share	136 Added 0.65%	20,631 Common Stock
Feb 21 2023	BUY Open market or private purchase	$1,201 $109.2 p/Share	11 Added 0.05%	20,495 Common Stock
Feb 15 2023	SELL Open market or private sale	$541,100 $108.22 p/Share	5,000 Reduced 19.78%	20,284 Common Stock
Dec 19 2022	BUY Open market or private purchase	$763 $109.04 p/Share	7 Added 0.03%	20,484 Common Stock
Dec 13 2022	BUY Open market or private purchase	$6,213 $110.96 p/Share	56 Added 0.27%	20,477 Common Stock
Dec 06 2022	BUY Open market or private purchase	$3,281 $109.39 p/Share	30 Added 0.15%	20,421 Common Stock
Dec 05 2022	BUY Open market or private purchase	$11,720 $109.54 p/Share	107 Added 0.52%	20,391 Common Stock

Also insider at

KMB

KIMBERLY CLARK CORP Consumer Defensive

Director